MapLight Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Novo Holdings A/S | — | C | 2,733,681 | — | — | 2,733,681 | Oct 28, 2025 |
| Catalyst4, Inc. | — | C | 14,256,288 | — | — | 14,256,288 | Oct 28, 2025 |
| Malenka Robert C. | — | Award / Grant | 34,390 | — | — | 399,671 | Oct 28, 2025 |
| Kroeger Christopher A. | Chief Executive Officer | Award / Grant | 225,693 | — | — | 225,693 | Oct 28, 2025 |
| Garnett Timothy John | — | Award / Grant | 6,294 | — | — | 6,294 | Oct 27, 2025 |
| Walker Maria C | — | Award / Grant | 6,294 | — | — | 6,294 | Oct 27, 2025 |
| Hanson Kristopher | General Counsel | Award / Grant | 27,098 | — | — | 27,098 | Oct 27, 2025 |
| GILLIS JONATHAN | CAAO and PAO | Award / Grant | 30,565 | — | — | 30,565 | Oct 27, 2025 |
| Kreitzer Anatol | Chief Discovery Officer | Award / Grant | 35,953 | — | — | 35,953 | Oct 27, 2025 |
| Lillie James Woodruff | Chief Scientific Officer | Award / Grant | 32,539 | — | — | 32,539 | Oct 27, 2025 |
| Setia Vishwas | Chief Financial Officer | Award / Grant | 43,367 | — | — | 43,367 | Oct 27, 2025 |
| Foff Erin Pennock | Chief Medical Officer | Award / Grant | 48,275 | — | — | 48,275 | Oct 27, 2025 |